Carlyle, the private equity giant, is among the suitors vying to buy Reckitt Benckiser’s infant nutrition arm in China as the world’s most populous nation grapples with a declining birth-rate.
Sky News has learnt that the buyout firm is among a number of parties who were preparing to table offers for the Greater China unit of Mead Johnson ahead of a deadline on Thursday.
Market sources said that Yili, one of the biggest existing players in the country’s infant nutrition market, was also expected to bid, alongside several other financial and strategic bidders.
Source: Sky News
By Mark Kleinman
